DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
299	嚢胞性線維症	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02723968 (ClinicalTrials.gov)	September 2009	21/3/2016	Cystic Fibrosis Related Diabetes Screening.	Sensitivity and Specificity of Different Methods for Cystic Fibrosis-related Diabetes Screening.	Cystic Fibrosis-related Diabetes	Other: glucose solution at a dose of 1.75 g/kg (up to a maximum of 75 g) for the OGTT and glucose solution at a dose of 0.5 g/kg (up to a maximum of 35 g) was injected in 2.5-3 min for the IGTT;Procedure: HGPIV diagnosis test;Procedure: HOMAR-IR diagnosis test	Hospices Civils de Lyon	NULL	Completed	10 Years	18 Years	All	29	N/A	NULL

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT02723968
(ClinicalTrials.gov)

September 2009

21/3/2016

Cystic Fibrosis Related Diabetes Screening.

Sensitivity and Specificity of Different Methods for Cystic Fibrosis-related Diabetes Screening.

Cystic Fibrosis-related Diabetes

Other: glucose solution at a dose of 1.75 g/kg (up to a maximum of 75 g) for the OGTT and glucose solution at a dose of 0.5 g/kg (up to a maximum of 35 g) was injected in 2.5-3 min for the IGTT;Procedure: HGPIV diagnosis test;Procedure: HOMAR-IR diagnosis test

Hospices Civils de Lyon

NULL

Completed

10 Years

18 Years

All

N/A

NULL